In one embodiment, an effective amount of Compound 1 Pattern 1 is administered in combination with an effective amount of dasatinib Sprycel for the treatment of leukemia, including acute lymphoblastic leukemia or chronic myelogenous leukemia <a href=https://propeci.cfd>finpecia canada</a>